Achieve Life Sciences (ACHV) Invested Capital (2016 - 2025)

Achieve Life Sciences' Invested Capital history runs 6 years deep, the most recent figure standing at $1.6 million for Q4 2025.

• Quarterly Invested Capital changed N/A year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $4.2 million (down 57.91% YoY) and the FY2025 annual result came in at $1.6 million, changed N/A from the prior year.
• Invested Capital was $1.6 million for Q4 2025 at Achieve Life Sciences, up from $1.4 million in the prior quarter.
• Across five years, Invested Capital topped out at $17.1 million in Q1 2024 and bottomed at $528000.0 in Q4 2023.
• A 4-year average of $7.1 million and a median of $1.6 million in 2025 frame the typical range for Invested Capital.
• Annual changes were most pronounced in 2023 — Invested Capital sank 96.71% — and 2024, when it gained 4.7%.
• Achieve Life Sciences' Invested Capital stood at $16.1 million in 2022, then sank by 96.71% to $528000.0 in 2023, then jumped by 1567.42% to $8.8 million in 2024, then plunged by 82.31% to $1.6 million in 2025.
• Business Quant data shows ACHV's Invested Capital at $1.6 million in Q4 2025, $1.4 million in Q3 2025, and $1.2 million in Q2 2025.